Zentalis Pharmaceuticals, Inc.
Ticker: 1725160
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2024 | Q1 FY2024 |
|---|---|---|
| INCOME | ||
| Revenue | 40.56+0.0% | 40.56 |
| Total Income | 40.56+0.0% | 40.56 |
| EXPENSES | ||
| Expenditure | 65.33+0.0% | 65.33 |
| Tax | 0.14+0.0% | 0.14 |
| PROFIT | ||
| PBT | 10.18+0.0% | 10.18 |
| Net Profit | 10.07+0.0% | 10.07 |
| KEY METRICS | ||
| OPM % | -61.06% | -61.06% |
| NPM % | 24.82% | 24.82% |
| EPS | 0.14+0.0% | 0.14 |
Corporate Events
Board MeetingZNTL
202616Jun
Board Meeting
Annual Meeting of Stockholders to elect Class III directors,…
SEC Filing ↗ Board MeetingZNTL
202622May
Board Meeting
Board of Directors increased its size and appointed Shannon …
SEC Filing ↗